Friday, October 29, 2010

KRC - Retail Research

SELL GLENMARK AT Rs 340

Long Term Investors can still hold the position in Glenmark Pharma with a target price of Rs. 390


Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)